Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMOSTEM for Engraftment and GvHD Prevention in Pediatric Acute Leukemia
NCT00823316Phase 2Completed
- Sponsor
- MEDIPOST
- Start
- Aug 2008
- Primary completion
- Feb 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Promostem in graft rejection, graft-versus-host disease (GVHD), sponsored by MEDIPOST. Started Aug 2008; status: completed.
02
Drugs
Promostem
03
Conditions
graft rejectiongraft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00823316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823316.